Sort by
Refine Your Search
-
number of measures used in any one study, many questions about the relationship between EFs and dyslexia remain unresolved. Here we take an innovative approach involving a) development of new, open-source
-
—to address critical sustainability and climate resilience challenges. Your primary focus will be on developing, refining, and deploying innovative genetic engineering tools for CRISPR-Cas9 delivery. Key
-
, with special emphasis on autism, depression, and addiction. There are ample opportunities for career development and clinical exposure based on candidate interest. Required Qualifications: The ideal
-
Childhood. (link is external) The program is designed to train fellows to conduct work that is equity-focused—centering systemic equity as an outcome interdisciplinary—examining individual development in
-
warehouses (e.g., electronic medical records and biobanks), implementation and evaluation opportunities in live healthcare systems, and professional development resources like (grant) writing workshops and
-
language processing (NLP) to augment clinical decision-making and expand access to high-quality healthcare. Our lab develops new methods to improve model trustworthiness and leverages heterogeneous clinical data
-
of physicists, engineers, and oceanographers interested in advancing our understanding of ocean science, water sustainability, and climate resilience. Our lab develops optical techniques based on spectroscopy
-
Substitution in the Blind; Ocular Structures and Physiology; MR Engineering and Methods Development for the Visual System. MRI experiments will mainly be conducted at research centers at the Stanford campus and
-
immunosuppression, akin to PDL1-PD1 interactions. In collaboration with Carolyn Bertozzi’s group, we are developing bifunctional proteins that include an antibody to cell surface cancer proteins (e.g. PSMA, CA9) and
-
for (1) engineering BPAN genetic variants into cell lines; (2) developing cellular assays including of autophagy function and cellular survival; (3) working with the Stanford high throughput drug screening